Skip to content
Disclosery

Boston Trust Walden Corp: ORCL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Boston Trust Walden Corp on ORCL, newest first. How the timeline and the estimate are built.

Boston Trust Walden Corp held 2,546,948 ORCL shares at 2026-06-30 per its 13F-HR filed 2026-08-04.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,546,948 shares
    Change vs previous 13F -328,211 shares

    0.3% of the 13F portfolio, value $371,117,112.

    13F-HR 0001386060-26-000035 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,219,661 shares
    • Boston Trust Walden Corp: 327,287 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,875,159 shares
    Change vs previous 13F -51,374 shares

    0.39% of the 13F portfolio, value $422,884,706.

    13F-HR 0001386060-26-000017 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,517,848 shares
    • Boston Trust Walden Corp: 357,311 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,926,533 shares
    Change vs previous 13F -657,667 shares

    0.52% of the 13F portfolio, value $571,174,020.

    13F-HR 0001386060-26-000014 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,529,091 shares
    • Boston Trust Walden Corp: 397,442 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,584,200 shares
    Change vs previous 13F -1,806,951 shares

    0.91% of the 13F portfolio, value $1,009,221,713.

    13F-HR 0001386060-25-000020 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,077,781 shares
    • Boston Trust Walden Corp: 506,419 shares

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F/A 5,391,151 shares
    Change vs previous 13F +27,818 shares

    1.14% of the 13F portfolio, value $1,185,591,326.

    13F-HR/A 0001085146-25-004915 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 4,813,379 shares
    • Boston Trust Walden Corp: 577,772 shares

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 5,363,333 shares
    Change vs previous 13F -1,504,457 shares

    0.78% of the 13F portfolio, value $747,597,921.

    13F-HR 0001085146-25-002987 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 4,775,191 shares
    • Boston Trust Walden Corp: 588,142 shares

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 6,867,790 shares
    Change vs previous 13F -876,499 shares

    1.19% of the 13F portfolio, value $1,149,072,323.

    13F-HR 0001085146-25-000961 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 6,303,760 shares
    • Boston Trust Walden Corp: 564,030 shares

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 7,744,289 shares
    Change vs previous 13F not available

    1.33% of the 13F portfolio, value $1,320,640,114.

    13F-HR 0001085146-24-005518 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 7,343,802 shares
    • Boston Trust Walden Corp: 400,487 shares

    Acceptance time not in the bulk data set (spec §4.2).